| MARUSIC, A.P., I. LOCATELLI, A. MRHAR, M. CAPRNDA, L. GASPAR, M. ADAMEK, Peter KRUŽLIAK and D. PETROVIC. Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients. Clinical and Applied Thrombosis-Hemostasis. Thousand Oaks: Sage Publications Inc., 2017, vol. 23, No 8, p. 938-942. ISSN 1076-0296. Available from: https://dx.doi.org/10.1177/1076029616689301. |
Other formats:
BibTeX
LaTeX
RIS
@article{1406942,
author = {Marusic, A.P. and Locatelli, I. and Mrhar, A. and Caprnda, M. and Gaspar, L. and Adamek, M. and Kružliak, Peter and Petrovic, D.},
article_location = {Thousand Oaks},
article_number = {8},
doi = {http://dx.doi.org/10.1177/1076029616689301},
keywords = {prevention of venous thromboembolism; red blood cells; vitamin K; blood replacement},
language = {eng},
issn = {1076-0296},
journal = {Clinical and Applied Thrombosis-Hemostasis},
title = {Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients},
volume = {23},
year = {2017}
}
TY - JOUR
ID - 1406942
AU - Marusic, A.P. - Locatelli, I. - Mrhar, A. - Caprnda, M. - Gaspar, L. - Adamek, M. - Kružliak, Peter - Petrovic, D.
PY - 2017
TI - Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients
JF - Clinical and Applied Thrombosis-Hemostasis
VL - 23
IS - 8
SP - 938-942
EP - 938-942
PB - Sage Publications Inc.
SN - 10760296
KW - prevention of venous thromboembolism
KW - red blood cells
KW - vitamin K
KW - blood replacement
N2 - Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups (P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.
ER -
MARUSIC, A.P., I. LOCATELLI, A. MRHAR, M. CAPRNDA, L. GASPAR, M. ADAMEK, Peter KRUŽLIAK and D. PETROVIC. Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients. \textit{Clinical and Applied Thrombosis-Hemostasis}. Thousand Oaks: Sage Publications Inc., 2017, vol.~23, No~8, p.~938-942. ISSN~1076-0296. Available from: https://dx.doi.org/10.1177/1076029616689301.
|
